Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Optic Neuromyelitis Spectrum Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Not Yet RecruitingNCT07341828
What this trial is testing

C-CAR168 in the Treatment of Central Nervous System Autoimmune Diseases Refractory to Standard Therapy

Who this might be right for
Multiple Sclerosis (MS)Neuromyelitis Optica Spectrum Disorders (NMOSD)Autoimmune Encephalitis+1 more
Huashan Hospital 15
Post-approval studies (Phase 4)Looking for participantsNCT07010302
What this trial is testing

Rituximab Versus Ravulizumab, Inebilizumab, Satralizumab, and Eculizumab in NMOSD

Who this might be right for
NMOSD
Massachusetts General Hospital 540
Not applicableStudy completedNCT01500681
What this trial is testing

Maintenance Plasma Exchange for Neuromyelitis Optica

Who this might be right for
Neuromyelitis OpticaNeuromyelitis Optica Spectrum DisorderRecurrent Idiopathic Longitudinally Extensive Transverse Myelitis
Mayo Clinic 9
Not applicableStudy completedNCT07032337
What this trial is testing

Efficacy and Safety of Conventional Immunosuppressant Therapies in Elderly Patients With Neuromyelitis Optica Spectrum Disorder

Who this might be right for
Neuromyelitis Optica Spectrum Disorder (NMOSD)
Samsung Medical Center 2,985
Early research (Phase 1)Looking for participantsNCT06249438
What this trial is testing

C-CAR168 in the Treatment of Autoimmune Diseases Refractory to Standard Therapy

Who this might be right for
Systemic Lupus Erythematosus (SLE)Immune-mediated Necrotizing Myopathy (IMNM)Neuromyelitis Optica Spectrum Disorders (NMOSD)+3 more
RenJi Hospital 30
Early research (Phase 1)Not Yet RecruitingNCT06633042
What this trial is testing

The Safety and Efficacy of Universal CAR-T Cells Targeting BCMA in the Treatment of Refractory NMOSD

Who this might be right for
Autoimmune Disease
Bioray Laboratories 18
Post-approval studies (Phase 4)UnknownNCT02809079
What this trial is testing

Mycophenolate Mofetil Treatment With Neuromyelitis Optica Spectrum Disorders in Chinese Patients

Who this might be right for
Neuromyelitis Optica Spectrum DisordersMycophenolate MofetilEfficacy and Safety
Third Affiliated Hospital, Sun Yat-Sen University 100
Testing effectiveness (Phase 2)Study completedNCT01845584
What this trial is testing

Phase II Clinical Trial of NPB-01 in Patients With Anti-aquaporin 4 Antibody Positive Neuromyelitis Optica Spectrum Disorder Not Provided Adequate Effect of Therapy to Steroids Plus Therapy.

Who this might be right for
Neuromyelitis Optica Spectrum Disorder
Nihon Pharmaceutical Co., Ltd 7
Testing effectiveness (Phase 2)Study completedNCT03062579
What this trial is testing

A Longitudinal Study of ACTEMRA® (Tocilizumab) as Monotherapy in Highly Active NMOSD

Who this might be right for
Neuromyelitis Optica Spectrum DisordersNeuromyelitis OpticaDevic's Disease
Fu-Dong Shi 10
Testing effectiveness (Phase 2)Study completedNCT05154734
What this trial is testing

Efficacy and Safety of Belimumab in Neuromyelitis Optica Spectrum Disorders

Who this might be right for
NMO Spectrum Disorder
Tianjin Medical University General Hospital 14
Not applicableLooking for participantsNCT06502015
What this trial is testing

Biomarkers in Autoimmune Disease of Nervous System

Who this might be right for
Autoimmune Diseases of the Nervous SystemNeuromyelitis Optica Spectrum DisorderMultiple Sclerosis+8 more
Tongji Hospital 50,000
Post-approval studies (Phase 4)UnknownNCT06212245
What this trial is testing

A Clinical Research Study of Inebilizumab in Neuromyelitis Optica Spectrum Disorders

Who this might be right for
Neuromyelitis Optica Spectrum Disorders
Hansoh BioMedical R&D Company 33
Early research (Phase 1)WithdrawnNCT03605238
What this trial is testing

Treatment of Relapsed and/or Refractory AQP4-IgG Seropositive NMOSD by Tandem CAR T Cells Targeting CD19 and CD20

Who this might be right for
Neuromyelitis Optica Spectrum Disorder
Chinese PLA General Hospital
Not applicableStudy completedNCT04355611
What this trial is testing

Epidemiological Characteristics of COVID-19 in Patients With MS or NMO

Who this might be right for
Multiple SclerosisNMO Spectrum DisorderCOVID-19
Assistance Publique - Hôpitaux de Paris 2,465
Early research (Phase 1)Looking for participantsNCT07526493
What this trial is testing

Safety and Pharmacodynamics of QH103 Cell Injection in the Treatment of Patients With Relapsed/Refractory Antibody-Mediated Neurological Autoimmune Diseases.

Who this might be right for
Multiple Sclerosis (MS)Neuromyelitis Optica Spectrum Disorder (NMOSD)Autoimmune Encephalitis (AE)+4 more
Tongji Hospital 6
Large-scale testing (Phase 3)Ended earlyNCT03330418
What this trial is testing

A Phase III Study of TACI-antibody Fusion Protein Injection (RC18) in Subjects With Neuromyelitis Optica Spectrum Disorders

Who this might be right for
Neuromyelitis Optica Spectrum Disorders
RemeGen Co., Ltd. 178
Not applicableEnded earlyNCT04131764
What this trial is testing

Diagnosis of ON With or Without MS or NMOSD

Who this might be right for
Multiple SclerosisNeuromyelitis Optica Spectrum Disorder AttackNeuromyelitis Optica Spectrum Disorder Relapse+2 more
Jagannadha R Avasarala 112
Early research (Phase 1)Study completedNCT04146285
What this trial is testing

A Phase I Clinical Trial of BAT4406F Injection in Patients With Neuromyelitis Optica Spectrum Disorders

Who this might be right for
Neuromyelitis Optica Spectrum Disorders
Bio-Thera Solutions 15
Not applicableEnded earlyNCT07247292
What this trial is testing

Epidemiological Study of Treatment Approaches on AQP4-IgG Positive NMOSD in Russia

Who this might be right for
Rare DiseasesNeuromyelitis Optica Spectrum Disorder (NMOSD)
AstraZeneca 3
Not applicableNot Yet RecruitingNCT07273292
What this trial is testing

Autonomic Dysfunction in Neuromyelitis Optica Spectrum Disorder and Multiple Sclerosis : A Comparative Study

Who this might be right for
NMO and MS
Mohamed Moshref abd alsattar 100
Next Page